Medical Condition News

RSS
Guardian Research Network, Molecular Health to provide therapeutic clinical trial access to cancer patients

Guardian Research Network, Molecular Health to provide therapeutic clinical trial access to cancer patients

FDA approves Humalog 200 units/mL KwikPen to improve glycemic control in diabetic patients

FDA approves Humalog 200 units/mL KwikPen to improve glycemic control in diabetic patients

Eli Lilly to present Phase III PROCLAIM trial results at ASCO Annual Meeting

Eli Lilly to present Phase III PROCLAIM trial results at ASCO Annual Meeting

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

Measuring kidney function and damage may help predict people at risk for heart disease

Measuring kidney function and damage may help predict people at risk for heart disease

MIT, UCSD researchers use probiotics to detect cancer in the liver

MIT, UCSD researchers use probiotics to detect cancer in the liver

New EU Clinical Trials Regulation may prove to be challenging for cancer research in Europe

New EU Clinical Trials Regulation may prove to be challenging for cancer research in Europe

RI-MUHC researchers receive $1.5 million to develop glutamate biosensor platform for brain diseases

RI-MUHC researchers receive $1.5 million to develop glutamate biosensor platform for brain diseases

Breakthrough in machine learning could revolutionize medical screening methods

Breakthrough in machine learning could revolutionize medical screening methods

DDW 2015: Experts explore efficacy of Stretta therapy for treating chronic GERD patients

DDW 2015: Experts explore efficacy of Stretta therapy for treating chronic GERD patients

Differences in brain expression of RORA protein levels may lead to sex bias in autism

Differences in brain expression of RORA protein levels may lead to sex bias in autism

Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

Study explores efficacy of selective serotonin reuptake inhibitors in reducing depressed mood

Study explores efficacy of selective serotonin reuptake inhibitors in reducing depressed mood

Array BioPharma presents clinical data of BRAF, MEK and HER2 drugs at 2015 ASCO Annual Meeting

Array BioPharma presents clinical data of BRAF, MEK and HER2 drugs at 2015 ASCO Annual Meeting

SDSU researchers awarded NIH grant to understand how autism plays out across the lifespan

SDSU researchers awarded NIH grant to understand how autism plays out across the lifespan

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

Researchers identify gaps in collective knowledge regarding trauma-related disorders

Researchers identify gaps in collective knowledge regarding trauma-related disorders

Study highlights recent trends in non-fatal suicidal events in the U.S. Army

Study highlights recent trends in non-fatal suicidal events in the U.S. Army

MedUni Vienna expert suggests pricing strategy to reduce smoking

MedUni Vienna expert suggests pricing strategy to reduce smoking

RPCI researchers develop individualized post-operative survival calculator for colon cancer patients

RPCI researchers develop individualized post-operative survival calculator for colon cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.